ASCO Lung Cancer Roundtable - Trial Updates in NSCLC - ADAURA Trial and Post Surgery EGFR Mutation

dbrock's picture
Trial Updates - NSCLC The ADAURA Trial - Potential Clinical Impact - Potentially Curative Setting in Adjuvant Therapy for Patients Post Surgery with EGFR Mutation
H. Jack West, MD, Founder, President and CEO
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.

Dr. Jack West has a virtual discussion with Helena A. Yu, MD, Medical Oncologist with Memorial Sloan Kettering, specializing in Lung Cancer and Targeted Therapies for Lung Cancer, and David Spigel, MD, Chief Scientific Officer; Director, Lung Cancer Research Program and Principal Investigator with Sarah Cannon.

Drs. West, Yu and Spigel discuss trial updates in non small cell lung cancer. For this video, the topic is the ADAURA Trial and it's potential clinical impact; a potentially curative setting in adjuvant therapy for patients post surgery with an EGFR mutation.



To join the conversation, visit



Video Language: 


Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation